Literature DB >> 3367788

Secondary hyperparathyroidism of morbid obesity regresses during weight reduction.

T Andersen1, P McNair, L Hyldstrup, N Fogh-Andersen, T T Nielsen, A Astrup, I Transbøl.   

Abstract

In order to test the relation between obesity and the secondary hyperparathyroidism found in markedly overweight subjects, 24 morbidly obese patients were studied before and after a weight loss of 35.9 kg obtained by a nutritionally adequate, intermittent very-low-calorie diet. Overweight was reduced from 98 +/- 34% to 44 +/- 19%. Serum total calcium did not change, but serum ionized calcium (Ca2+) increased from 1.22 +/- 0.04 mmol/L to 1.25 +/- 0.04 mmol/L (P less than .001). A corresponding fall was observed in serum parathyroid hormone (s-PTH), which decreased from 47.2 +/- 21.7 pmol/L to 35.2 +/- 19.4 pmol/L (P = .01). The change of s-PTH was positively associated with the reduction of body weight (r = .50, P less than .05) and with the reduction of overweight (r = .55, P less than .01). Regarding calcium binding substances, serum albumin remained low. The initially lowered serum phosphate and bicarbonate both rose (P less than .001). Plasma lactate and plasma free fatty acids (FFAs) decreased (P less than .001). The study supports our hypothesis that the change profile of calcium complexing anions in obesity interferes with the tubular reabsorption of calcium, which in turn lowers serum Ca2+, thus promoting hyperparathyroidism. Along with weight loss, concentrations of calcium complexing anions returns towards normal values and the secondary hyperparathyroidism regresses.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3367788     DOI: 10.1016/0026-0495(88)90041-8

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  10 in total

1.  Serum leptin, parathyroid hormone, 1,25-dihydroxyvitamin D, fibroblast growth factor 23, bone alkaline phosphatase, and sclerostin relationships in obesity.

Authors:  Elizabeth Grethen; Kathleen M Hill; RoseMarie Jones; Brenda M Cacucci; Christine E Gupta; Anthony Acton; Robert V Considine; Munro Peacock
Journal:  J Clin Endocrinol Metab       Date:  2012-02-22       Impact factor: 5.958

2.  Energy restriction reduces bone density and biomechanical properties in aged female rats.

Authors:  S M Talbott; M Cifuentes; M G Dunn; S A Shapses
Journal:  J Nutr       Date:  2001-09       Impact factor: 4.798

3.  True fractional calcium absorption is decreased after Roux-en-Y gastric bypass surgery.

Authors:  Claudia S Riedt; Robert E Brolin; Robert M Sherrell; M Paul Field; Sue A Shapses
Journal:  Obesity (Silver Spring)       Date:  2006-11       Impact factor: 5.002

Review 4.  Bone, body weight, and weight reduction: what are the concerns?

Authors:  Sue A Shapses; Claudia S Riedt
Journal:  J Nutr       Date:  2006-06       Impact factor: 4.798

5.  The high serum monocyte chemoattractant protein-1 in obesity is influenced by high parathyroid hormone and not adiposity.

Authors:  D Sukumar; N C Partridge; X Wang; S A Shapses
Journal:  J Clin Endocrinol Metab       Date:  2011-04-20       Impact factor: 5.958

6.  Vitamin D and hyperparathyroidism in obesity.

Authors:  Elizabeth Grethen; Ronald McClintock; Christine E Gupta; RoseMarie Jones; Brenda M Cacucci; David Diaz; Angie D Fulford; Susan M Perkins; Robert V Considine; Munro Peacock
Journal:  J Clin Endocrinol Metab       Date:  2011-02-16       Impact factor: 5.958

Review 7.  Forearm Fractures in Overweight-Obese Children and Adolescents: A Matter of Bone Density, Bone Geometry or Body Composition?

Authors:  Roberto Franceschi; Giorgio Radetti; Massimo Soffiati; Evelina Maines
Journal:  Calcif Tissue Int       Date:  2022-03-22       Impact factor: 4.000

8.  The association of adiposity with parathyroid hormone in healthy older adults.

Authors:  Arpita Patel Pitroda; Susan S Harris; Bess Dawson-Hughes
Journal:  Endocrine       Date:  2009-08-27       Impact factor: 3.633

9.  Impact of Roux-en-Y gastric bypass versus sleeve gastrectomy on vitamin D metabolism: short-term results from a prospective randomized clinical trial.

Authors:  Michel Vix; Keng-Hao Liu; Michele Diana; Antonio D'Urso; Didier Mutter; Jacques Marescaux
Journal:  Surg Endosc       Date:  2013-11-07       Impact factor: 4.584

10.  Serum markers of bone turnover are increased at six and 18 months after Roux-en-Y bariatric surgery: correlation with the reduction in leptin.

Authors:  Carolina Bruno; Angie D Fulford; Jenna R Potts; Ronald McClintock; Rosemarie Jones; Brenda M Cacucci; Christine E Gupta; Munro Peacock; Robert V Considine
Journal:  J Clin Endocrinol Metab       Date:  2009-10-26       Impact factor: 5.958

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.